Discover whether oral medications for gestational diabetes cost less than insulin, based on SUGAR-DIP trial findings on expenses and safety.
Read More »The SGLT2 Hemoglobin Effect: A Clue to Cardiorenal Protection?
Learn how SGLT2 inhibitors affect hemoglobin and hematocrit, and what a JAMA meta-analysis reveals about possible heart and kidney benefits.
Read More »Can Better Self-Management Protect the Kidneys Before Damage Takes Hold?
Can better diabetes self-management protect kidney health? Explore new trial findings on A1C, blood pressure, cholesterol, and kidney function.
Read More »When Antibiotics Aren’t Enough: Phage Therapy Takes on Diabetic Foot Infections
Discover how BX211 bacteriophage therapy may improve diabetic foot ulcer healing, what Phase 2 trial results reveal, and why further research is needed.
Read More »Could a Saliva Test Replace the Glucose Drink in Pregnancy? The Science Isn’t There Yet
Can saliva tests detect gestational diabetes? Explore promising salivary biomarkers, new research findings, and why blood tests remain essential.
Read More »Metformin Before the ICU: A Surprising Kidney Signal Challenges the Usual Narrative
A new ICU study links prior metformin use to lower odds of acute kidney injury. Explore the findings, limitations, and implications for diabetes care.
Read More »The Symptoms Were There: Why Was Type 1 Diabetes Still Missed?
Discover why type 1 diabetes symptoms are often missed in children, how diagnostic delays increase DKA risk, and what clinicians can do to improve detection.
Read More »Shine a Light on Diabetic Nerve Pain? A Sham-Controlled Trial Tests the Idea
Can laser therapy relieve diabetic neuropathy pain? Explore new clinical trial findings, treatment benefits, limitations, and what patients should know.
Read More »Does Every Person With Type 1 Diabetes Really Need a Foot Exam Every Year?
Discover what the OPTI-ONE study reveals about type 1 diabetes foot screening, annual exams, and whether low-risk patients need fewer visits.
Read More »A New DME Drug Matched Anti-VEGF on Vision: Could Retina Care Be Ready for a New Option?
Discover how remigromig performed against anti-VEGF therapy in the BRUNELLO trial and what AAO 2026 findings mean for diabetic macular edema care.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.